If You Invested $1,000 in Johnson & Johnson in January, This Is How Much You Would Have Today
Investors shouldn't expect quick sky high returns from healthcare giant Johnson & Johnson (NYSE: JNJ). In 2020, many investors are probably happy if they've managed to avoid losing a significant chunk of their investments. Even though the markets are doing well of late, many healthcare stocks are still struggling amid the COVID-19 pandemic. For example, shares of drugmaker Merck are down 12% year to date -- and that's still better than biotech stock Arrowhead Pharmaceuticals, which has plummeted 29% over the same period. The lesson of 2020 is this: Whether we're in a bull or bear market, investors need to be diligent when choosing which stocks to invest in for the long-haul, because some stocks are tougher to break than others.
Johnson & Johnson is one of the safer stocks you can invest in, no matter the current climate. Its consumer health brands, including Aveeno, Neutrogena, and Band-Aid, are popular all over the world, and its diverse segments ensure that its financials remain stable, making the stock an attractive long-term investment. Johnson & Johnson is resilient in good times and bad -- even during a global pandemic. Let's take a look at how much you could've made if you bought shares of the company back in January.
Image source: Getty Images.
Source Fool.com
